According to Cognitive Market Research, the global Core Needle Biopsy Device market size was USD 6854.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 15.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 2741.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2056.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1576.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 342.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 137.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.
The direct sales emerge as the dominant distribution channel. This approach allows manufacturers to maintain close relationships with healthcare providers, ensuring a deeper understanding of their needs and preferences
